https://novaprd-lb.newcastle.edu.au/vital/access/manager/Index ${session.getAttribute("locale")} 5 Adjuvant letrozole versus tamoxifen according to centrally-assessed ERBB2 status for postmenopausal women with endocrine-responsive early breast cancer: supplementary results from the BIG 1-98 randomised trial https://novaprd-lb.newcastle.edu.au/vital/access/manager/Repository/uon:4800 Sat 24 Mar 2018 07:20:39 AEDT ]]> Tumor-infiltrating lymphocytes and prognosis: a poled individual patient analysis of early-stage triple-negative breast cancers https://novaprd-lb.newcastle.edu.au/vital/access/manager/Repository/uon:34339 Mon 03 Feb 2020 11:52:07 AEDT ]]>